Swiss - Delayed Quote CHF
Roche Holding AG (ROG.SW)
259.30
+1.70
+(0.66%)
As of 4:45:10 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 20 | 19 |
Avg. Estimate | 0 | 0 | 19.95 | 21.15 |
Low Estimate | 0 | 0 | 18.25 | 19.49 |
High Estimate | 0 | 0 | 21.72 | 22.71 |
Year Ago EPS | -- | -- | 18.8 | 19.95 |
Revenue Estimate
Currency in CHF | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 18 | 18 |
Avg. Estimate | 15.95B | 16.02B | 63.29B | 65.94B |
Low Estimate | 15.95B | 16.02B | 60.74B | 62.4B |
High Estimate | 15.95B | 16.02B | 66.44B | 70.34B |
Year Ago Sales | 15.45B | 15.14B | 60.49B | 63.29B |
Sales Growth (year/est) | 3.24% | 5.81% | 4.61% | 4.19% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 19.95 | 21.15 |
7 Days Ago | 0 | 0 | 20.06 | 21.28 |
30 Days Ago | 0 | 0 | 20.75 | 22.13 |
60 Days Ago | 0 | 0 | 20.92 | 22.12 |
90 Days Ago | 0 | 0 | 20.58 | 22.05 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | 3 | 11 |
Down Last 30 Days | -- | -- | 13 | 10 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ROG.SW | -- | -- | 6.13% | 5.99% |
S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Related Tickers
NOVN.SW Novartis AG
91.11
+0.22%
NVS Novartis AG
108.56
-0.13%
BAYN.DE Bayer Aktiengesellschaft
24.04
-0.04%
SAN.PA Sanofi
90.25
+1.40%
AZN.L AstraZeneca PLC
10,246.00
+0.06%
AZN AstraZeneca PLC
67.84
+0.40%
SNY Sanofi
50.13
+0.46%
NOV.DE Novo Nordisk A/S
59.10
-0.25%
NOVO-B.CO Novo Nordisk A/S
441.40
-0.65%
BIIB Biogen Inc.
123.55
+4.55%